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ABSTRACT:
Diabetes mellitus, commonly known as diabetes, is a non-communicable disease whereby a person’s pancreas 
is either incapable of producing or unable to use insulin in the body. The disease and its complications are 
growing in different parts of the world. It has been predicted that by 2035, there will be over 205 million diabetics 
in the world. It has been hypothesized that diabetes complications is highly prevalent in many African countries 
due to high medication cost, lack of early diagnoses and treatment, low economic standing, and culture-
influenced beliefs about the disease. To address this hypothesis, a literary review was conducted on peer-
reviewed articles. PubMed and Google Scholar were searched using the keywords: diabetes, diabetes in 
Africa, diabetes complications to retrieve these articles. The articles were read and evaluated by one reviewer 
and information was extracted to generate conclusion about the hypothesis. The research found that the high 
influx of diabetes complications in Sub-Saharan Africa is correlated with the low economic status of countries 
within this region. Also high reliance on traditional medicine leading to delayed treatment also influences the 
prevalence of complications.This research also sought to identify the most effective preventative measures for 
these complications (e.g. optimal diet, exercise, access to effective medications) and the availability of these 
measures in the Sub-Saharan African regions. It was determined that countries in Sub-Saharan Africa lacked 
access to optimal medications, which is the most effective preventative measure. Future studies should focus on 
ways to improve this preventive measure to optimize diabetes control in these regions.
Le diabète sucré, connu communément sous le nom de diabète, est une maladie non-transmissible qui surgit 
lorsque le pancréas d’une personne est incapable de produire de l’insuline ou est incapable d’utiliser l’insuline 
produite. Des prévisions montrent qu’à l’an 2035 , il y aura plus de 205 millions de diabétiques dans le monde. Il 
y a une hypothèse que la situation économique de pays subsahariens et la culture contribuent aux complications 
diabétiques de ces régions. De la recherche a été conduite dans des journaux révisé par des pairs afin de prouver 
ou de réfuter cette hypothèse. Il a été découvert qu’il y a une corrélation directe entre le statut économique et 
culturel de pays en Afrique subsaharienne et le taux élevé de complications provoqués par le diabète sucré. Cette 
recherche a aussi été ciblée pour rechercher les mesures préventatives pour éviter ces complications et pour 
augmenter la disponibilité de ces mesures. Il a été déterminé que ces pays manquaient ces mesures préventives 
et efficaces. Des études futures devraient se concentrer sur des moyens d’installation de ces mesures afin de 
sauver des vies.
INTRODUCTION:
Diabetes mellitus is a non-communicable disease whereby a person’s pancreas is either incapable of creating 
or utilizing the bodily insulin.1 There are different forms of diabetes with type I and II being the most common. 
The exact cause of type I diabetes is currently unknown, but it is speculated to be autoimmune associated. 
Thus, it cannot be prevented and it is often characterized by the body’s inability to produce insulin.2 The onset 
of type II diabetes is caused by the body’s inability to utilize the insulin that is created, and is speculated to be 
contributed mostly by obesity. In fact, obesity accounts for 90% of diabetes cases.3 Approximately 90% of the 
people in the world with diabetes have type II diabetes.4 Diabetes afflicts 347 million people in the world, with 
over 80% of cases affecting individuals in low-income countries.4
People with diabetes are at a higher risk of developing other diseases than non-diabetic individuals. Diabetic 
complications can be categorized as micro- and macrovascular.5 Microvascular complications are a result of 
small blood vessel damage, and may include retinopathy (damage to the eye potentially leading to blindness), 
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nephropathy (damage to the kidneys potentially 
causing kidney failure), and neuropathy (nerve damage 
consequently leading to loss of limbs and/or senses).6 
Diabetic neuropathy is the most common of these 
complications, leading to the need for amputations 
of the limbs of the lower extremity.7 In contrast, 
macrovascular complications occur due to damage in 
the large blood vessels, and include diseases related 
to the cardiovascular system.4 Through a process 
called atherosclerosis, hyperglycemia causes the 
damage of large blood vessels. This decreases the 
inner circumference of arteries preventing blood from 
flowing through them easily to the heart, the brain, 
and other parts of the body. The end results are heart 
attacks and strokes, as well as decreased healing of 
infections.4 Complications are not exclusive to any one 
type of diabetes, patients with either type I or type II 
diabetes experience a variety of these complications. 
The focus of this study was to discover if economic 
and cultural factors are what increase the likelihood of 
diabetes complications in Africa, specifically in Sub-
Saharan countries. It was also hypothesized that Sub-
Saharan African countries do not have the effective 
preventive measures available to save the lives of 
their diabetics. This research was conducted, due to 
a lack of knowledge of the epidemiology of diabetic 
complications in Sub-Saharan African countries.
METHOD:
Multiple scientific journal articles from 2008 and 
onwards were researched on the databases PubMed 
and Google Scholar using the keywords: diabetes, 
diabetes in Africa, and diabetes complications to 
retrieve these articles. The articles were reviewed 
and evaluated based on their content and relevance 
to the topic. Articles with just abstracts available were 
not considered, only full-text articles were viewed. The 
qualitative and quantitative reports of the articles were 
noted and compared in order to form a conclusion. 
RESULTS:
It was observed that the lowest proportion, less than 1%, 
of global health expenditure on diabetes is in Africa.6
• For every 10,000 people in Africa, there are 2
doctors and 11 midwives or nurses available.4
• 76%of diabetes-related deaths in Sub-Saharan
Africa occurred in people below the age of 60.6
• Africa experiences at least 63% of the world’s
undiagnosed diabetes.6
DISCUSSION
The primary treatment and monitoring device for 
diabetes is insulin and the glucose meter respectively. 
Due to the high cost of insulin and glucose meters, 
many diabetics in Sub-Saharan Africa are unable 
to afford these important tools.8 Lack of insulin can 
lead to poor glycemic control, which is one of the 
leading causes for diabetic complications.8 High 
costs of medications and treatment devices drive 
people to rely on traditional, less effective 
medicines for a cure. Many traditional healers 
promise a cure at reasonable costs; however, their 
knowledge on diabetes may be limited or out-dated. 
In the early stages of their illness, most Africans 
seek out traditional healers and only seek hospital 
care after they had already developed 
complications as a result of their ailments.8
In this study, it was observed that the most 
effective measure to prevent diabetic 
complications is good glycemic control through 
healthy living and optimal medicine treatments.9 
Unfortunately, many people in Sub-Saharan 
Africa are unfamiliar with optimal exercise 
regimes and healthy eating habits as a remedy 
to prevent diabetes, because they (and their health 
care workers) are not well informed of these 
matters.10 Ultimately, the availability of medication, 
constant monitoring, and adopting of good health 
habits can either prevent the onset of diabetes or 
detect the illness in its early stages, but are often 
inaccessible to patients in Africa. 
In fact, when patients seek hospital care, they 
are often misdiagnosed with other common 
diseases such as malaria, due to lack of 
knowledge related to diabetes-related illnesses. 
By the time a proper diagnosis is made, the 
disease has progressed into its late stages and 
complications have begun to occur. Due to the 
fact that obvious complications and symptoms occur 
during the late stages of diabetes, there is little 
incentive to fund diabetes-related research and 
initiatives in Africa. Thus, diabetes is not viewed 
as a widespread epidemic, compared to 
communicable diseases such as HIV/AIDS and 
tuberculosis, which have plagued the continent for 
ages. This lack of acknowledgement makes 
constant monitoring of diabetes a challenge 
because patients 
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do not have regular access to doctors. Additionally, 
the health care system in many African countries is 
quite poor in terms of finances and adequacy, leading 
to the unavailability of treatment and adequate 
treatment facilities for diabetes.8 Specifically, the 
lack of adequate health care and education in Sub-
Saharan Africa hinders the ability of diabetics to attain 
good glycemic control and therefore enables the 
prevalence of diabetes complications
CONCLUSION
Diabetes afflicts large masses of people around the 
world, the majority of which are in Africa, specifically 
in the Sub-Saharan regions. Many of these diabetic 
cases can cause mortality, because diabetic patients 
in Sub-Saharan Africa encounter serious diabetic 
complications due to socioeconomicbarriers such 
as poverty and cultural barriers such as the belief 
in traditional healers. As shown in the literature, the 
most effective prevention against type II diabetes 
complications is proper glycemic control, which can 
be achieved through proper education on lifestyle 
changes and improved accessibility to effective 
medications. Non-communicable diseases such 
as diabetes warrant greater attention from African 
governmentsto ensure optimal management 
andimproved quality of life in all affected citizens. 
Additionally, the reluctance of diabetics in Africa to 
see doctors and rely on traditional healers should 
be taken into consideration when determining 
how to optimally control and prevent diabetes 
complications. Thus, it is recommended that the 
African governments invest in educating traditional 
healers and health care practitioners, in order to 
properly inform and diagnose their patients. 
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